VALORANT player profile · Europe region · Account level 446 · Title “Twisten” · 0 profile views
Current rank: IMMORTAL 1 - 13 RR (as of last recorded competitive match, 2026-06-05).
Peak recorded rank: IMMORTAL 1 - 43 RR (reached 2026-05-31).
Ranks derive from recorded ranked matches; games played while untracked may not be reflected.
| Tracked matches | 92 |
|---|---|
| Win rate | 63.6% (14 W / 8 L over 23 matches with recorded stats) |
| K/D | 1.07 (373 kills / 350 deaths / 116 assists) |
| Average combat score | 1936 |
| Headshot rate | 19.0% |
| Date | Mode | Map | Agent | Result | K/D/A | ACS | RR |
|---|---|---|---|---|---|---|---|
| 2026-08-02 | Competitive | Ascent | Sova | L | 1/5/0 | 69 | - |
| 2026-07-22 | Team Deathmatch | Kasbah | Yoru | L | 23/15/0 | 5815 | - |
| 2026-07-01 | Competitive | Lotus | Skye | L | 15/21/11 | 192 | - |
| 2026-06-28 | Competitive | Split | Clove | W | 25/28/12 | 254 | - |
| 2026-06-25 | Competitive | Lotus | Fade | L | 13/16/8 | 214 | - |
| 2026-06-17 | Competitive | Fracture | Skye | W | 14/15/10 | 214 | - |
| 2026-06-05 | Competitive | Fracture | - | - | - | - | +13 |
| 2026-06-04 | Competitive | Haven | - | - | - | - | -25 |
| 2026-06-01 | Competitive | Lotus | - | - | - | - | +0 |
| 2026-06-01 | Competitive | Pearl | Killjoy | W | 12/14/6 | 176 | +13 |
| 2026-05-31 | Competitive | Ascent | - | - | - | - | -26 |
| 2026-05-31 | Competitive | Breeze | Phoenix | W | 21/14/4 | 268 | +13 |
| 2026-05-31 | Competitive | Pearl | - | - | - | - | -26 |
| 2026-05-31 | Competitive | Fracture | - | - | - | - | +14 |
| 2026-05-30 | Competitive | Haven | - | - | - | - | +12 |
| 2026-05-30 | Competitive | Pearl | - | - | - | - | +14 |
| 2026-05-30 | Competitive | Lotus | - | - | - | - | -23 |
| 2026-05-30 | Competitive | Split | Miks | W | 13/13/11 | 193 | +13 |
| 2026-05-30 | Competitive | Lotus | - | - | - | - | +13 |
| 2026-05-30 | Competitive | Breeze | - | - | - | - | -24 |
Showing 20 of 92 tracked matches. The interactive profile lists all of them.
No penalty records for this player.